Bausch Health Companies Inc. (BHC.TO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Thomas J. Appio | CEO & Director | 4.24M | -- | 1962 |
| Ms. Seana Carson | Executive VP & General Counsel | 1.4M | -- | 1973 |
| Ms. Aimee J. Lenar | Executive Vice President of US Pharma | 1.27M | -- | -- |
| Mr. Mirza Dautbegovic | Executive VP & COO | -- | -- | -- |
| Mr. Garen Sarafian | VP & Head of Investor Relations | -- | -- | -- |
| Ms. Kathleen Fitzpatrick | Executive VP and Chief HR & Communications Officer | -- | -- | -- |
| Mr. Cees Heiman | Senior Vice President of Europe & Canada | -- | -- | -- |
| Mr. Donald Pearl | Senior Vice President of Ortho Dermatologics | -- | -- | -- |
| Ms. Jiny Kim M.B.A. | Senior Vice President of Solta Medical | -- | -- | 1977 |
| Dr. Jonathan Sadeh M.D., M.Sc. | Executive VP, Chief Medical Officer and Head of R&D | -- | -- | -- |
Bausch Health Companies Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 20,700
Description
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Corporate Governance
Upcoming Events
July 30, 2025 at 12:30 PM UTC - August 4, 2025 at 12:30 PM UTC
Bausch Health Companies Inc. Earnings Date
Recent Events
November 10, 2010 at 12:00 AM UTC
Ex-Dividend Date